Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 3Urinary Bladder Neoplasms 1Pancreatic carcinoma, familial 1Pancreatic Intraductal Neoplasms 1Cranial Nerve Diseases 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

tocotrienol, delta 1dehydroftorafur 1X-Rays 1Therapeutic Irrigation 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sulindac 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Pancreatectomy 1Octreotide 1Magnetic Resonance Spectroscopy 1Hydrocortisone 1Gemcitabine 1Fluorouracil 1Ferrosoferric Oxide 1Erlotinib Hydrochloride 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Intraductal Neoplasms × Ferrosoferric Oxide × 1 year × Clear all
NCT02070705 2025-07-31

DCE MRI in Patients With Pancreatic Cancer

OHSU Knight Cancer Institute

Phase NA Terminated
77 enrolled
Gastrointestinal

Pancreatic carcinoma, familial, Pancreatic Intraductal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡